SCHEMBL3019775

SCHEMBL3019775

C/C(=C/C(=O)O)c1ccc(NC(=O)c2cc([Si](C)(C)C)cc([Si](C)(C)C)c2)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
RARA P10276 1/20 0.42
RARB P10826 1/20 0.42
RARG P13631 1/20 0.42
SNCA P37840 1/20 0.40
HDAC1 Q13547 2/20 0.38
MAOB P27338 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
ABCC9 O60706 1/20 0.36
ABCC8 Q09428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3019774 1.00 NPC1 (0.42) NPC1RAB9ARARARARBRARG
SCHEMBL3019778 1.00 NPC1 (0.42) NPC1RAB9ARARARARBRARG
SCHEMBL3012218 0.87 RAB9A (0.44) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3028911 0.87 RAB9A (0.43) NPC1RAB9AMAOBSMN1; SMN2MEN1
SCHEMBL3028908 0.87 RAB9A (0.43) NPC1RAB9AMAOBSMN1; SMN2MEN1
SCHEMBL3012216 0.87 RAB9A (0.44) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL3028912 0.87 RAB9A (0.43) NPC1RAB9AMAOBSMN1; SMN2MEN1
SCHEMBL3012222 0.87 RAB9A (0.44) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL18123261 0.85 RARA (0.55) NPC1RAB9ARARARARBRARG
SCHEMBL3019610 0.83 CACNA1B (0.43) NPC1RAB9ASNCAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7855300-B2 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2010-12-21 US disclosed
US-20100210591-A1 BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 2010-08-19 US disclosed
EP-2202235-A1 BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210591-A1 BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF RARA, RARB, RXRA NPC1 2845/4885RAB9A 1306/4885RARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.